(Q66034501)
Statements
Open Label Phase II Study on XR5000 Administered as a 5 Day Infusion in Advanced Non Small Cell Lung Cancer (English)
0 references
September 1999
0 references
November 2000
0 references
15
0 references
18 year
0 references